SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-069408
Filing Date
2023-08-21
Accepted
2023-08-21 16:30:10
Documents
13
Period of Report
2023-08-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183997-8k_aditxt.htm   iXBRL 8-K 29683
2 AMENDMENT TO SEPARATION AGREEMENT AND GENERAL RELEASE DATED AUGUST 15, 2023 ea183997ex10-1_aditxt.htm EX-10.1 12847
  Complete submission text file 0001213900-23-069408.txt   222037

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20230815.xsd EX-101.SCH 3009
4 XBRL LABEL FILE adtx-20230815_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20230815_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT ea183997-8k_aditxt_htm.xml XML 3393
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 231189521
SIC: 2834 Pharmaceutical Preparations